2-Cyano-4-methylpent-2-enoic acid → HCID 123659276, compound
Reaction equation
[NH:1]1[CH2:4][CH:3]([N:5]2[C:9]3=[N:10][CH:11]=[N:12][C:13]([NH2:14])=[C:8]3[C:7]([C:15]3[CH:20]=[CH:19][C:18]([O:21][C:22]4[CH:27]=[CH:26][CH:25]=[CH:24][CH:23]=4)=[CH:17][C:16]=3[F:28])=[N:6]2)[CH2:2]1.[C:29]([C:31](=[CH:35][CH:36]([CH3:38])[CH3:37])[C:32](O)=[O:33])#[N:30].C1CN([P+](ON2N=NC3C=CC=NC2=3)(N2CCCC2)N2CCCC2)CC1.F[P-](F)(F)(F)(F)F>C(Cl)Cl>[NH2:14][C:13]1[N:12]=[CH:11][N:10]=[C:9]2[N:5]([CH:3]3[CH2:2][N:1]([C:32]([C:31](=[CH:35][CH:36]([CH3:38])[CH3:37])[C:29]#[N:30])=[O:33])[CH2:4]3)[N:6]=[C:7]([C:15]3[CH:20]=[CH:19][C:18]([O:21][C:22]4[CH:27]=[CH:26][CH:25]=[CH:24][CH:23]=4)=[CH:17][C:16]=3[F:28])[C:8]=12Participants
5
Procedure
The mixture of 1-(azetidin-3-yl)-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-4-amine (80 mg, 0.210 mmol, 2-cyano-4-methyl-pent-2-enoic acid (44.4 mg, 0.320 mmol), PyAOP (121.9 mg, 0.230 mmol) and TEA (0.09 mL, 0.640 mmol) in DCM (3 mL), were stirred overnight at room temperature. The solvent was removed and the residue was purified on a silica gel plate using 6:94 MeOH:CH2Cl2 to get 2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]azetidine-1-carbonyl]-4-methyl-pent-2-enenitrile (34 mg) as white powder. LC-MS (ES, m/z): 498 [M+H].
Workup
- customThe solvent was removed
- customthe residue was purified on a silica gel plate
Sources & evidence
- ORD record
- ord-f18bf3bcbec644558bc36d6486be00b6
- Source dataset
- uspto-grants-2015_01
- Patent number
- US08940744B2
Reaction notes
Loading…